SOPHIA FELDER: Open Payments
NPI 1043722523 · PORT ANGELES, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 65 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $297 · 2025 $1,915
Food & beverage: $1,900Education: $15
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $424 |
| GENZYME CORPORATION | 8 | $309 |
| ABBVIE INC. | 14 | $303 |
| Regeneron Healthcare Solutions, Inc. | 6 | $212 |
| Organon LLC | 5 | $185 |
| UCB, Inc. | 7 | $137 |
| Incyte Corporation | 2 | $137 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $98 |
| Lilly USA, LLC | 2 | $38 |
| Galderma Laboratories, L.P. | 1 | $35 |
Products named: DUPIXENT, OTEZLA, RINVOQ, VTAMA, Opzelura, SKYRIZI, Bimzelx, ILUMYA.
Industry payments across WA — which companies pay providers there.
